Ira Pastor is the CEO of Bioquark Inc., a U.S. life sciences company focused on biologic solutions for human regeneration, disease reversion, and age rejuvenation and has 30+ years of experience across multiple sectors of the pharmaceutical industry including pharmaceutical commercialization, biotech drug development, managed care, distribution, and retail. Ira has served as vice president of Business Development for drug development company Phytomedics Inc., raising $40 million of private equity, consummating over $50 million of licensing deals, and bringing a lead drug candidate from discovery stage to Phase III development. Prior to that, he was employed by SmithKline Beecham Pharmaceuticals in sales, marketing, and business strategy positions. He has also served as vice president of Corporate Development for the pharmacy benefit management company Prescription Delivery Systems (acquired by Cigna Health Insurance). He is a board member of RegenerAge SAPI de CV (www.regenerage.clinic/en), the Reanima Project (www.reanima.tech), and a member of the World Economic Forum's Human Enhancement Council (https://www.weforum.org/people/ira-pastor).
To learn more about Ira Pastor and his work, please visit bioquark.com.
Sorry we couldn't complete your registration. Please try again.
You must accept the Terms and conditions to register